Fertility-Sparing Surgery for Ovarian Cancer.
borderline ovarian
conservative surgery
epithelial ovarian cancer
fertility sparing surgery
ovarian cancer
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
18 Sep 2021
18 Sep 2021
Historique:
received:
18
08
2021
revised:
13
09
2021
accepted:
15
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
(1) Background: although most patients with epithelial ovarian cancer (EOC) undergo radical surgery, patients with early-stage disease, borderline ovarian tumor (BOT) or a non-epithelial tumor could be offered fertility-sparing surgery (FSS) depending on histologic subtypes and prognostic factors. (2) Methods: we conducted a systematic review to assess the safety and fertility outcomes of FSS in the treatment of ovarian cancer. We queried the MEDLINE, PubMed, Cochrane Library, and Cochrane ("Cochrane Reviews") databases for articles published in English or French between 1985 and 15 January 2021. (3) Results: for patients with BOT, FSS should be offered to young women with a desire to conceive, even if peritoneal implants are discovered at the time of initial surgery. Women with mucinous BOT should undergo initial unilateral salpingo-oophorectomy, whereas cystectomy is an acceptable option for women with serous BOT. Assisted reproductive technology (ART) can be initiated in patients with stage I BOT if infertility persists after surgery. For patients with EOC, FSS should only be considered after staging for women with stage IA grade 1 (and probably 2, or low-grade in the current classification) serous, mucinous or endometrioid tumors. FSS could also be offered to patients with stage IC grade 1 (or low-grade) disease. For women with serous, mucinous or endometrioid high-grade stage IA or low-grade stage IC1 or IC2 EOC, bilateral salpingo-oophorectomy and uterine conservation could be offered to allow pregnancy by egg donation. Finally, FSS has a large role to play in patients with non- epithelial ovarian cancer, and particularly women with malignant ovarian germ cell tumors.
Identifiants
pubmed: 34575345
pii: jcm10184235
doi: 10.3390/jcm10184235
pmc: PMC8466872
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Hum Reprod. 2000 Nov;15(11):2347-50
pubmed: 11056130
Am J Surg Pathol. 1985 Aug;9(8):543-69
pubmed: 3911780
Medicine (Baltimore). 2020 Sep 25;99(39):e22146
pubmed: 32991408
Ann Oncol. 2019 May 1;30(5):672-705
pubmed: 31046081
Gynecol Oncol. 2020 May;157(2):411-417
pubmed: 32115229
Eur J Surg Oncol. 2020 May;46(5):888-892
pubmed: 31722834
Maturitas. 2017 Feb;96:45-50
pubmed: 28041594
Obstet Gynecol. 2017 Jul;130(1):71-79
pubmed: 28594773
Hum Reprod. 2007 Feb;22(2):578-85
pubmed: 17050549
Aust N Z J Obstet Gynaecol. 1999 May;39(2):243-5
pubmed: 10755789
Ann Oncol. 2008 Aug;19(8):1435-1441
pubmed: 18408223
Gynecol Oncol. 2019 Aug;154(2):323-327
pubmed: 31189500
Reprod Biomed Online. 2008 Aug;17(2):265-7
pubmed: 18682002
Oncologist. 2018 Mar;23(3):324-327
pubmed: 29242280
Eur J Gynaecol Oncol. 2012;33(1):93-5
pubmed: 22439414
Fertil Steril. 2015 Nov;104(5):1319-24
pubmed: 26149354
J Clin Oncol. 2003 Mar 15;21(6):1180-9
pubmed: 12637488
Medicine (Baltimore). 2018 Oct;97(42):e12865
pubmed: 30334998
J Surg Oncol. 2009 Jul 1;100(1):55-8
pubmed: 19402079
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6956-64
pubmed: 25400781
Br J Cancer. 2011 Oct 25;105(9):1288-94
pubmed: 21970882
Eur J Cancer. 2015 Mar;51(4):543-550
pubmed: 25514863
Obstet Gynecol. 2003 Feb;101(2):251-7
pubmed: 12576247
Gynecol Oncol. 2014 Jan;132(1):23-7
pubmed: 24219980
CA Cancer J Clin. 1989 May-Jun;39(3):135-54
pubmed: 2496897
J Zhejiang Univ Sci B. 2011 Oct;12(10):787-95
pubmed: 21960341
Ann Oncol. 2014 Jul;25(7):1320-1327
pubmed: 24618151
Gynecol Oncol. 2005 Jun;97(3):845-51
pubmed: 15896834
Lancet Oncol. 2012 Mar;13(3):e103-15
pubmed: 22381933
Hum Reprod. 2010 Aug;25(8):1966-72
pubmed: 20573679
Gynecol Oncol. 2020 Apr;157(1):29-35
pubmed: 32241341
Eur J Cancer. 1992;28A(12):1971-3
pubmed: 1419292
Hum Reprod. 2006 Dec;21(12):3241-5
pubmed: 16893916
Obstet Gynecol. 1995 Sep;86(3):367-72
pubmed: 7651644
Obstet Gynecol. 2000 Apr;95(4):541-7
pubmed: 10725486
Fertil Steril. 2007 Aug;88(2):479-84
pubmed: 17408624
Int J Clin Oncol. 2019 Jul;24(7):857-862
pubmed: 30771039
Arch Gynecol Obstet. 2011 Nov;284(5):1253-8
pubmed: 21170543
Fertil Steril. 2005 Feb;83(2):284-90; quiz 525-6
pubmed: 15705364
Int J Gynaecol Obstet. 2016 Jul;134(1):49-52
pubmed: 27039052
Cancer. 2009 Sep 15;115(18):4118-26
pubmed: 19670446
Ann Surg Oncol. 2012 Mar;19(3):941-7
pubmed: 21879267
Am J Obstet Gynecol. 2014 Dec;211(6):637.e1-6
pubmed: 24949545
Eur J Gynaecol Oncol. 2004;25(3):315-20
pubmed: 15171308
Br J Cancer. 2016 Sep 6;115(6):641-8
pubmed: 27537385
Indian J Surg Oncol. 2018 Jun;9(2):215-219
pubmed: 29887704
J Obstet Gynaecol Res. 2019 Jul;45(7):1311-1318
pubmed: 31106943
Cancer. 2000 Jul 15;89(2):391-8
pubmed: 10918171
Cancer Res Treat. 2015 Apr;47(2):290-7
pubmed: 25287480
Obstet Gynecol. 2000 Jan;95(1):128-33
pubmed: 10636515
Case Rep Oncol. 2020 Jul 31;13(2):935-940
pubmed: 32884543
J Adolesc Young Adult Oncol. 2017 Jun;6(2):270-276
pubmed: 28085535
Int J Gynaecol Obstet. 2013 Apr;121(1):53-5
pubmed: 23352733
Arch Gynecol Obstet. 2005 Feb;271(2):104-8
pubmed: 15007601
Ann Surg Oncol. 2021 Jul;28(7):3597-3604
pubmed: 33140251
Gynecol Oncol. 2009 Apr;113(1):75-82
pubmed: 19171373
J Int Med Res. 2019 Oct;47(10):4895-4903
pubmed: 31432738
Hum Reprod. 1994 Nov;9(11):2032-3
pubmed: 7868669
J Med Case Rep. 2017 Dec 17;11(1):350
pubmed: 29248013
Ann Oncol. 2014 Jul;25(7):1312-1319
pubmed: 24713312
J Clin Oncol. 1999 Sep;17(9):2670-75
pubmed: 10561340
Eur J Cancer. 2018 Mar;91:30-37
pubmed: 29331749
Gynecol Oncol. 2018 Nov;151(2):275-281
pubmed: 30219238
Eur J Cancer. 2013 May;49(8):1905-14
pubmed: 23490647
Ecancermedicalscience. 2020 May 06;14:1035
pubmed: 32419847
J Pediatr Adolesc Gynecol. 2018 Feb;31(1):48-54
pubmed: 28899828
Cancer. 2001 Jul 15;92(2):320-5
pubmed: 11466685
Cochrane Database Syst Rev. 2013 Aug 13;(8):CD008215
pubmed: 23943232
Hum Reprod. 2011 Apr;26(4):808-14
pubmed: 21262776
J Korean Med Sci. 2007 Sep;22 Suppl:S134-8
pubmed: 17923740
Hum Reprod Update. 2013 Mar-Apr;19(2):151-66
pubmed: 23242913
Gynecol Oncol. 2002 Jul;86(1):34-7
pubmed: 12079297
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820946423
pubmed: 32783505
J Clin Diagn Res. 2017 May;11(5):XD01-XD02
pubmed: 28658892
J Clin Med. 2021 Apr 13;10(8):
pubmed: 33924415
J Obstet Gynaecol Res. 2014 Mar;40(3):797-805
pubmed: 24320102
J Obstet Gynaecol. 2011 May;31(4):327-9
pubmed: 21534756
BMC Cancer. 2020 Apr 15;20(1):320
pubmed: 32293358
Ann Oncol. 2012 Oct;23 Suppl 7:vii20-6
pubmed: 22997450
Br J Obstet Gynaecol. 1997 Sep;104(9):1030-5
pubmed: 9307530
J Clin Oncol. 2010 Apr 1;28(10):1727-32
pubmed: 20194858
Fertil Steril. 2007 Mar;87(3):591-6
pubmed: 17113086
Gynecol Oncol. 1999 Sep;74(3):515-8
pubmed: 10479523
World J Surg Oncol. 2017 Aug 15;15(1):154
pubmed: 28806962
Gynecol Oncol. 2008 Oct;111(1):106-10
pubmed: 18656249
Mol Clin Oncol. 2020 Jan;12(1):44-50
pubmed: 31832189
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv1-iv18
pubmed: 29697741
Gynecol Obstet Invest. 2014;77(1):1-5
pubmed: 23796887
Gynecol Oncol. 2008 Sep;110(3):345-53
pubmed: 18586310
Fertil Steril. 2004 Sep;82(3):568-72
pubmed: 15374697
Eur J Cancer. 2015 Feb;51(3):340-51
pubmed: 25559616
Gynecol Oncol. 2008 Dec;111(3):523-6
pubmed: 18538833
Br J Obstet Gynaecol. 1996 Sep;103(9):931-2
pubmed: 8813318
Gynecol Oncol. 1994 Dec;55(3 Pt 2):S47-51
pubmed: 7835811
Int J Clin Oncol. 2020 Jan;25(1):187-194
pubmed: 31541363
Gynecol Obstet Invest. 2016;81(1):1-9
pubmed: 25967958
Int J Gynecol Cancer. 2009 Oct;19(7):1199-204
pubmed: 19823055
Int J Gynaecol Obstet. 2020 Aug;150(2):169-176
pubmed: 32415982
Gynecol Oncol. 2002 Oct;87(1):1-7
pubmed: 12468335
Asian Pac J Cancer Prev. ;18(8):2083-2087
pubmed: 28843226
Obstet Gynecol Sci. 2017 May;60(3):289-295
pubmed: 28534015
Eur J Obstet Gynecol Reprod Biol. 2011 Jun;156(2):204-8
pubmed: 21306816
Cancer. 1999 May 15;85(10):2232-44
pubmed: 10326703
Eur J Obstet Gynecol Reprod Biol. 2007 Sep;134(1):110-4
pubmed: 16859821
Eur J Cancer. 2019 Apr;111:61-68
pubmed: 30826658
Acta Obstet Gynecol Scand. 2006;85(12):1496-500
pubmed: 17260228
Hum Reprod. 2004 Jun;19(6):1472-5
pubmed: 15105388
Hum Reprod. 2016 Aug;31(8):1732-7
pubmed: 27496944
Gynecol Oncol. 2007 Feb;104(2):396-400
pubmed: 17030354
J Obstet Gynaecol. 2018 Jan;38(1):143-145
pubmed: 28780898
Eur J Surg Oncol. 2010 Apr;36(4):404-8
pubmed: 20116965
Int J Gynecol Cancer. 2017 Nov;27(9):1833-1841
pubmed: 28816706
J Gynecol Oncol. 2009 Mar;20(1):44-7
pubmed: 19471664
Hum Reprod. 2005 May;20(5):1379-85
pubmed: 15817592
Oncologist. 2019 May;24(5):702-709
pubmed: 30201740
Gynecol Oncol. 2015 Jul;138(1):78-82
pubmed: 25969349
J Obstet Gynaecol India. 2020 Feb;70(1):50-56
pubmed: 32030006
Hum Reprod. 2020 Feb 29;35(2):328-339
pubmed: 32048711
Arch Gynecol Obstet. 2020 Jul;302(1):203-208
pubmed: 32430758
Ann Oncol. 2016 Nov;27(11):1994-2004
pubmed: 27502723
Gynecol Oncol. 2017 Jun;145(3):513-518
pubmed: 28372870
Eur J Gynaecol Oncol. 2003;24(3-4):223-32
pubmed: 12807228
Am J Obstet Gynecol. 2018 Oct;219(4):385.e1-385.e7
pubmed: 30086295
J Obstet Gynaecol. 2015 May;35(4):331-5
pubmed: 25383508
Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:97-102
pubmed: 24507757
Ann Oncol. 2013 Jan;24(1):138-44
pubmed: 22945381
J Clin Oncol. 2001 Feb 15;19(4):1015-20
pubmed: 11181664